Long-Term Follow-Up of Surgical Outcomes for Patients With Wilms Tumor and Neuroblastoma

Why This Matters

Pediatric oncology has achieved remarkable cure rates for Wilms tumor and neuroblastoma — survival now extends decades 0:11. But surgical resection is not the endpoint of surgical care [q2]. These patients carry long-term risks that outlast standard oncologic surveillance 0:58, and the patterns differ by tumor type in ways that should shape how we counsel families and structure follow-up.

The Core Problem

Open oncologic resection for retroperitoneal and abdominal tumors in children creates durable anatomic changes: adhesions, altered mesenteric relationships, radiation-induced fibrosis in some cases, and in Wilms tumor, loss of a kidney. The question is not whether late complications occur — we know they do — but when, how often, and whether the risk profile differs enough between tumor types to warrant different surveillance strategies.

What This Study Found

A single-institution cohort followed survivors for a mean of 27 years after open resection 0:11. This is unusually long follow-up for surgical outcomes research and captures complications that emerge well beyond the window most studies examine.

Fourteen percent of patients required a repeat laparotomy 0:20. The most common indications were small bowel obstruction or tumor recurrence 0:21. That reoperation rate is not trivial, and the timing pattern is the clinically useful finding: in Wilms tumor, obstruction typically occurred within the first year 0:26, but in neuroblastoma, obstruction often developed more than a decade later, well beyond routine follow-up 0:29.

This divergence matters 0:26 0:29. A Wilms tumor patient who makes it past the first postoperative year without obstruction has largely cleared that hurdle. A neuroblastoma survivor remains at risk into adolescence and young adulthood, long after oncology has signed off. The mechanism is likely multifactorial — neuroblastoma resections often involve more extensive retroperitoneal dissection, and radiation fields differ — but the practical implication is that neuroblastoma survivors need explicit counseling about late obstruction risk 0:58 and a lower threshold for imaging if they present with abdominal pain years later.

Radiation dose was not associated with reoperation risk 0:34, which runs counter to the intuitive assumption that higher doses would increase adhesive complications. This may reflect the dominant role of surgical factors over radiation effect, or it may be a power issue in a modest-sized cohort.

Other Late Effects

Secondary malignancy was uncommon in this cohort 0:37, which is reassuring given the known carcinogenic potential of both chemotherapy and radiation. Hypertension after nephrectomy was not increased compared to population norms 0:37, suggesting that a solitary kidney in this context does not impose the hypertensive burden seen in some other nephrectomy populations, though this finding should be interpreted cautiously given that hypertension risk accumulates with age and this cohort's mean follow-up, while long, may not yet capture the full lifetime risk.

Scoliosis occurred in roughly 10 to 13% of patients, higher than the general population 0:45. The contributors are multifactorial, including surgery and possibly radiation 0:45. This is not a surgical emergency, but it is a quality-of-life issue that warrants screening 0:45, particularly in patients who received flank incisions or radiation fields that included the spine.

What This Means for Practice

The central teaching point is that surgical care does not end at resection [q2]. Even decades after treatment, these patients remain at risk for late complications that warrant long-term counseling and follow-up 0:58.

For referring clinicians, this means:

• Wilms tumor survivors should be counseled about obstruction risk in the first postoperative year 0:26. After that, the risk drops. Routine surveillance can follow standard oncologic protocols.

• Neuroblastoma survivors need explicit counseling that obstruction risk persists for more than a decade 0:29. If an adolescent or young adult neuroblastoma survivor presents to an emergency department with abdominal pain, the surgical history is not ancient — it is relevant. A low threshold for CT is appropriate.

• Scoliosis screening should be part of long-term follow-up for both groups 0:45, particularly in patients who received flank incisions or spinal radiation 0:45.

• Hypertension screening after nephrectomy should follow population guidelines, not an intensified protocol, based on this cohort's findings 0:37, though longer follow-up may yet reveal increased risk.

The broader implication is that survivorship care for these patients requires coordination beyond oncology 0:58. Primary care physicians and adult medicine colleagues need to know the surgical history and the specific late risks. A young adult with a history of neuroblastoma resection in early childhood is not simply a cancer survivor — they are a patient with an altered surgical anatomy and a persistent risk of obstruction that their current providers may not recognize unless someone tells them.

Why This Matters

Pediatric oncology has achieved remarkable cure rates for Wilms tumor and neuroblastoma, but cure is not the end of the clinical story 0:11. These children undergo major abdominal or retroperitoneal surgery during critical growth periods, often combined with chemotherapy and radiation 0:11. The question for any physician managing these survivors—whether in primary care, adult oncology, or subspecialty practice—is what surgical sequelae persist or emerge years after treatment ends 0:11. This study provides rare long-term data: a mean follow-up of 27 years after open oncologic resection 0:11.

The Core Problem

Open resection for these tumors involves extensive retroperitoneal dissection, often with nephrectomy for Wilms tumor or complex nodal clearance for neuroblastoma 0:11. The surgical field overlaps with structures that will be stressed by decades of growth, movement, and aging 0:11. Adhesions form 0:21. Radiation fields stiffen tissue 0:45. The spine is still developing 0:45. The question is not whether late complications occur, but which ones, when, and in whom 0:58.

What Happens Over Decades

Repeat Laparotomy

14% of patients required a repeat laparotomy during follow-up 0:20. The most common indications were small bowel obstruction or tumor recurrence 0:21. What matters clinically is the timing, which differs sharply by tumor type 0:26 0:29. In Wilms tumor, obstruction typically occurred within the first year 0:26—a pattern familiar to pediatric surgeons managing early postoperative adhesions. In neuroblastoma, obstruction often developed more than a decade later, well beyond routine follow-up 0:29.

This delayed presentation in neuroblastoma survivors has practical implications 0:29. A young adult with abdominal pain and a history of infant neuroblastoma resection may not volunteer that surgical history, and the emergency physician may not think to ask 0:29. The obstruction is not early postoperative; it is a late effect of a childhood operation, emerging in adulthood when oncology follow-up has long since ended 0:29.

Radiation dose was not associated with re-operation risk 0:34, which runs counter to the intuition that higher radiation would increase adhesive complications. The finding suggests that the surgical disruption itself, rather than radiation-induced fibrosis, drives most of the obstruction risk 0:34—though the study does not rule out radiation as a contributor to other late effects 0:34.

Other Late Effects

Secondary malignancy was uncommon in this cohort 0:37, a reassuring finding given the known carcinogenic risk of both chemotherapy and radiation. Hypertension after nephrectomy was not increased compared to population norms 0:37, which may surprise clinicians who assume single-kidney status confers hypertension risk. The data here suggest that in the absence of other renal injury, a solitary functioning kidney from childhood nephrectomy does not reliably produce hypertension decades later 0:37.

Scoliosis occurred in a subset of patients, higher than the general population 0:45. The contributors are multi-factorial, including surgery and possibly radiation 0:45. Retroperitoneal dissection disrupts paraspinal musculature and fascia during active spinal growth 0:45. Radiation to a hemithorax or flank can asymmetrically inhibit vertebral body growth 0:45. Disentangling surgical from radiation effects in any individual patient is not possible, but the elevated rate makes scoliosis screening a reasonable component of long-term follow-up 0:45 0:45.

When to Think About This

For pediatric oncologists and surgeons, the implication is straightforward: counsel families at the time of treatment that surgical care does not end at resection, and that surveillance should extend beyond the typical oncologic window 0:58. For adult providers, the challenge is recognizing these patients when they present 0:29. A young adult with unexplained bowel obstruction and a childhood cancer history warrants early surgical consultation and a low threshold for imaging 0:29. A primary care physician seeing a young adult with mild scoliosis should ask about childhood abdominal surgery, not just idiopathic causes 0:45.

The study does not define specific follow-up protocols, but the data support the principle that even decades after treatment, these patients remain at risk for late complications that warrant long-term counseling and follow-up 0:58. In practice, this means transitioning care thoughtfully from pediatric oncology to adult providers who understand the surgical history, and ensuring that patients themselves know their anatomy and risk profile well enough to advocate for appropriate workup when symptoms arise 0:58.

What Remains Uncertain

This is a single-institution cohort, and surgical technique, radiation planning, and chemotherapy regimens have all evolved over the study span 0:11. Whether contemporary approaches—smaller incisions, more precise radiation, less toxic chemotherapy—will reduce these late effects is unknown 0:11. The study also does not address functional outcomes: whether patients with scoliosis have pain or disability, whether those with repeat laparotomy return to baseline function, or how these complications affect quality of life 0:58. Those questions require different study designs, but they matter to patients and families weighing treatment intensity against long-term burden 0:58.